/CU6
CU6
Updated 25 May 08:16 am
$2.71
CLARITY PHARMACEUTICALS LTD
1D+5.88%
1M+0.56%
1Y+28.11%
Track your position in CU6
Sign in to TradeLedgr to record trades in CU6 (CLARITY PHARMACEUTICALS LTD) with parcel-level precision and ATO-compliant reporting.
Recent Announcements
20 May 2026 6:57 AM
Cleansing Notice240KB
Cleansing Notice
20 May 2026 6:54 AM
Application for quotation of securities - CU620KB
Appendix 2A
13 May 2026 11:43 PM
Clarity receives $9.8 million R&D tax incentive refund168KB
Periodic Reports - Other
30 Apr 2026 2:24 AM
Quarterly Activities/Appendix 4C Cash Flow Report2948KB
Commitments Test Entity - Third Quarter Activity Report
22 Apr 2026 6:23 AM
Change of Director's Interest Notice - Parker421KB
Change of Director's Interest Notice
Fundamentals
P/E Ratio
-99999.99x
Div Yield
0.00%
EPS
$-0.2794
Avg Vol
2.2M
52W High
$5.870
52W Low
$1.840
Company Profile
Clarity is a clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology.
Corporate WebsiteFinancial History
2025A
$-64.3M profit
$0.0M rev
2024A
$-42.3M profit
$0.0M rev
2023A
$-24.6M profit
$0.0M rev